WCM
ACHV icon

Windsor Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Windsor Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Hold
10,817
– – 0.02% 127
2026
Q1 		$31.8K Hold
10,817
– – 0.01% 123
2025
Q4 		$53.8K Hold
10,817
– – 0.01% 121
2025
Q3 		$34.1K Hold
10,817
– – 0.01% 121
2025
Q2 		$24.4K Hold
10,817
– – 0.01% 120
2025
Q1 		$28.9K Hold
10,817
– – 0.01% 118
2024
Q4 		$38.1K Hold
10,817
– – 0.01% 119
2024
Q3 		$51.3K Buy
+10,817
New +$49.4K 0.01% 119

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Windsor Capital Management's ACHV Position: Q2 2026 in Review

Windsor Capital Management held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 10,817 shares worth $70.6K. The position accounts for 0.02% of the portfolio, ranked #127.

Windsor Capital Management first reported a position in ACHV in Q3 2024 and has held it in 8 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Windsor Capital Management held 10,817 shares of Achieve Life Sciences worth $70.6K as of Q2 2026.
  • Windsor Capital Management left its Achieve Life Sciences share count unchanged in Q2 2026.
  • Achieve Life Sciences made up 0.02% of Windsor Capital Management's portfolio in Q2 2026, its #127 holding.
  • Windsor Capital Management first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.